Results 131 to 140 of about 9,116 (181)

Genome and drug resistance analysis of <i>Mycobacterium abscessus</i> complex on tropical islands in China. [PDF]

Front Microbiol
Wang J, Li C, Zheng X, Chen Z, Ye W, Xu Y, Qiu W, Chen S, Pei H, Zhong Y.   +9 more
europepmc   +1 more source

Effect of biofilm formation on the antimicrobial activity of tigecycline against <i>Mycobacterium abscessus</i> in the hollow fiber infection model. [PDF]

Front Microbiol
Park H, Maloney Norcross SE, Hickey AJ, Gonzalez-Juarrero M, Meibohm B.   +4 more
europepmc   +1 more source

Refractory Tunnel Infections Caused by Multidrug-Resistant Mycobacterium abscessus Requiring Peritoneal Dialysis Catheter Removal. [PDF]

Cureus
Morino T, Shibuya K, Shin T, Noguchi T.
europepmc   +1 more source

Sulbactam-durlobactam plus ceftriaxone dosing and novel treatment regimens for <i>Mycobacterium abscessus</i> lung disease. [PDF]

Antimicrob Agents Chemother
Singh S, Shrivastava A, Boorgula GD, Long MC, Robbins B, McShane PJ, Gumbo T, Srivastava S.   +7 more
europepmc   +1 more source

CRISPRi-mediated <i>in vivo</i> gene silencing: a tool for prioritizing drug targets in <i>Mycobacterium abscessus</i>. [PDF]

Antimicrob Agents Chemother
Gupta R, Simcox BS, Rohde KH.
europepmc   +1 more source

Systematic and quantitative analyses of hollow fiber model of <i>Mycobacterium abscessus</i> lung disease studies and new dosing recommendations. [PDF]

Microbiol Spectr
Srivastava S, Gumbo T.
europepmc   +1 more source

Prodrug florfenicol amine is activated by intrinsic resistance to target Mycobacterium abscessus. [PDF]

Nat Microbiol
Phelps GA, Kurt S, Jenner AR, Anderson SM, Jayasinghe TD, Griffith EC, Thompson CW, Yang L, Wicki B, Bright FK, Loudon V, Wright WC, Srivastava A, Singh A, Thalluri B, Park H, Lee RB, Wright AK, Grant-Chapman O, Conner DK, Troyer BT, Iverson A, Ochoado J, Pagala VR, Wu L, Byrum S, Fu Y, Yuan ZF, High AA, Schulthess B, Rosch JW, Geeleher P, Hobbie SN, Boeck L, Meibohm B, Obregon-Henao A, Sander P, Lee RE.   +37 more
europepmc   +1 more source

Eravacycline for <i>Mycobacterium abscessus</i> infections: pharmacodynamic advantages of long-acting post-antibiotic effects and weekly dosing regimens. [PDF]

Microbiol Spectr
Ying R, Yang G, Huang X, Wang J, Wang L, Sha W.   +5 more
europepmc   +1 more source

Establishing a competence model in discriminating <i>Mycobacterium</i> species and <i>Mycobacterium abscessus</i> subspecies by using surface-enhanced Raman spectroscopy. [PDF]

Biomed Rep
Pichitphorn A, Faksri K, Kaewseekhao B, Potisap C, Duong Thai T, Eisiri J, Juntagran C, Namwat W, Khwansirikul P, Salao K, Chaisri S, Phoksawat W.   +11 more
europepmc   +1 more source